Susan Horvath - Net Worth and Insider Trading
Susan Horvath Net Worth
The estimated net worth of Susan Horvath is at least $10 dollars as of 2024-11-07. Susan Horvath is the V.P. of Finance & CFO of Panbela Therapeutics Inc and owns about 30 shares of Panbela Therapeutics Inc (PBLA) stock worth over $10. Details can be seen in Susan Horvath's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Susan Horvath has not made any transactions after 2023-01-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Susan Horvath
Susan Horvath Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susan Horvath owns 1 companies in total, including Panbela Therapeutics Inc (PBLA) .
Click here to see the complete history of Susan Horvath’s form 4 insider trades.
Insider Ownership Summary of Susan Horvath
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PBLA | Panbela Therapeutics Inc | 2023-01-30 | V.P. of Finance & CFO |
Susan Horvath Latest Holdings Summary
Susan Horvath currently owns a total of 1 stock. Susan Horvath owns 30 shares of Panbela Therapeutics Inc (PBLA) as of January 30, 2023, with a value of $10.
Latest Holdings of Susan Horvath
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PBLA | Panbela Therapeutics Inc | 2023-01-30 | 30 | 0.35 | 10 |
Holding Weightings of Susan Horvath
Susan Horvath Form 4 Trading Tracker
According to the SEC Form 4 filings, Susan Horvath has made a total of 1 transactions in Panbela Therapeutics Inc (PBLA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Panbela Therapeutics Inc is the acquisition of 7 shares on January 30, 2023, which cost Susan Horvath around $6,799.
Insider Trading History of Susan Horvath
- 1
Susan Horvath Trading Performance
GuruFocus tracks the stock performance after each of Susan Horvath's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Susan Horvath is -64.12%. GuruFocus also compares Susan Horvath's trading performance to market benchmark return within the same time period. The performance of stocks bought by Susan Horvath within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Susan Horvath's insider trading performs compared to the benchmark.
Performance of Susan Horvath
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -36.73 | | | | | |
| Relative Return to S&P 500(%) | -35.82 | | | | | |
Susan Horvath Ownership Network
Ownership Network List of Susan Horvath
Ownership Network Relation of Susan Horvath
Susan Horvath Owned Company Details
What does Panbela Therapeutics Inc do?
Who are the key executives at Panbela Therapeutics Inc?
Susan Horvath is the V.P. of Finance & CFO of Panbela Therapeutics Inc. Other key executives at Panbela Therapeutics Inc include director & President and CEO Jennifer K. Simpson , 10 percent owner Ryan Randall Gilbertson , and 10 percent owner Ryan R. Gilbertson 2012 Irrevocable Trust .
Panbela Therapeutics Inc (PBLA) Insider Trades Summary
Over the past 18 months, Susan Horvath made no insider transaction in Panbela Therapeutics Inc (PBLA). Other recent insider transactions involving Panbela Therapeutics Inc (PBLA) include a net sale of 72,874 shares made by Goldman Sachs Group Inc ,
In summary, during the past 3 months, insiders sold 0 shares of Panbela Therapeutics Inc (PBLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,644 shares of Panbela Therapeutics Inc (PBLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,644 shares.
Panbela Therapeutics Inc (PBLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Panbela Therapeutics Inc Insider Transactions
Susan Horvath Mailing Address
Above is the net worth, insider trading, and ownership report for Susan Horvath. You might contact Susan Horvath via mailing address: 4645 Ithaca Lane, Plymouth Mn 55446.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
